Results CALENDAR
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
May 2013 12345678910111213141516171819202122232425262728293031
India Earnings >> Current News
  You are here : Home » Parenteral Drugs (India) »
Parenteral Drugs (India)
* Last Announced: Jun 07 Result
 Current News
1
Parenteral Drugs sells its arm's Goa unit, stock falls 9%       15th-Mar-2013
Parenteral Drugs (India) dropped nearly 18 percent from day's high on Friday after the company sold its subsidiary's Goa unit to Fresenius Kabi.
Will use sale proceeds to diversify operations: Parenteral         15th-Mar-2013
Parenteral Drugs (India) sold their IV Fluid manufacturing unit at Goa to Fersenius Kabi India (P) Limited for Rs 200 crore.
Parenteral Drugs expects topline growth of 50% in FY11-12         28th-Dec-2010
With decent performance in FY10-11, Parenteral Drugs is likely to see topline growth of 50% in FY11-12. In an exclusive interview with CNBC-TV18, CEO of Parenterall Drugs says that among the three mainline of businesses –oncology, critical care and formulations;
Parenteral Drugs India declares bonus in ratio of 1:3       15th-Sep-2010
Parenteral Drugs India has declared bonus in the ratio of 1:3.
Parenteral Drugs BOD meeting on September 02, 2010       27th-Aug-2010
Parenteral Drugs has its Board of Directors meeting on September 02, 2010 to consider and approve the audited annual accounts, dividend & bonus.
Oncology biz to grow 250% this year: Parenteral Drugs         5th-Aug-2010
Parental Drugs intends to focus on formulations and oncology outside of its more profitable intravenous fluids business. Its revenues are expected to be boosted with its tie-up with New Delhi's Jawaharlal Nehru University for research and development
See good growth in Q4: Parenteral Drugs         11th-Mar-2010
In an interview with CNBC-TV18, Anil Mittal, CEO, Parenteral Drugs, spoke about the latest happenings in his company and sector.
Almaty proj to start production in Dec'10: Parenteral Drugs         15th-Jan-2010
In an interview with CNBC-TV18, Anil Mittal, Chief Executive Officer, Parenteral Drugs, speaks about the latest happenings in his company and sector.
Parenteral Drugs Promoters to dilute 11.34% stake       17th-Dec-2007
Parenteral Drugs (India) Ltd one of the market leaders and pioneers in manufacturing of IV fluids in polypropylene bottles and eye/ear drops and formulations (solid and liquid orals) announced dilution of the promoter’s stake by 11.34%.
Parenteral Drugs registers 446.87% growth in net profit       1st-Nov-2007
Parenteral Drugs (India) Ltd registers 446.87% growth in net profit in total income stands at Rs 52.80 crores for quarter ended September 07
Parenteral Drugs sales increase has been 19.50%       7th-Aug-2007
Parenteral Drugs (India) Limited's sales increase has been 19.50%

Results so Far

Search

 Best Performers
 Worst Performers
 Positive Turnarounds
 Negative Turnarounds
 Latest Results
 Sector Performance
Most Visited
 Results Calendar
 Board Meetings
 Book Closures
 Dividend Calendar
 Brokerage Reports
 FII Comments
 Pre Result Estimates
 Results At A Glance
 Interview With Management
 CNBC TV18 Live Video
Results at a glance
SpiceJet narrows March quarter loss... May 24
Crompton Greaves Q4 net plunges 75%... May 24
eClerx Q4 Net up 58% at Rs 48.16 cr... May 24
more
Press Releases
Pre Result Estimates
SpiceJet likely to post Q4 net loss... May 24
Crompton Q4: Analysts expect 30% fa... May 24
Factors that will impact JSW Steel'... May 23
more
Management Talk
Hotel Leela plans to cut down debt ... May 24 Watch Video
Hopeful of maintaining profit from ... May 24 Watch Video
JSW Steel confident of 9-10% growth... May 23 Watch Video
more
FII Comments
more
Analyst View
Tata Steel may not maintain Q4 EBIT... May 24 Watch Video
Tata Steel stock gains: How brokera... May 24
How to play SBI after Q4 results mi... May 23 Watch Video
more
CNBC TV18 View
Indian pharmas gain on N America bo... May 09 Watch Video
more
Brokerage Reports
Buy Reliance Infra; target of Rs 64... May 24
Buy ILandFS Transportation; target ... May 24
Buy Entertainment Network: Ventura... May 24
more
Press Conferences
Dip in Q4 net fails to dent L&T's m... May 22 Watch Video
Excise duty, higher input costs hur... May 21 Watch Video
We will refocus on growth in 2013-1... May 13 Watch Video
more
Analyst Concalls
more
Source : Dion Global Solutions Limited